文献速递心境障碍精神分裂症与精神病性障碍

精神分裂症多基因易感性与双相障碍心境不一致精神病性症状的关联

Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder.
PubMed 文献 · JAMA Psychiatry · 2018-01-01

英国病例对照研究纳入4436例双相障碍、4976例精神分裂症和9012名对照,采用多项逻辑回归分析精神分裂症多基因风险评分与双相障碍精神病性表现的关系。结果显示多基因风险评分与精神分裂症关联最强,其次为分裂情感性双相障碍、双相I型、双相II型;双相障碍内心境不一致精神病性特征关联最强,存在暴露-反应梯度。

要点

  • 精神分裂症多基因风险评分与双相障碍精神病性表现呈梯度关联。
  • 双相障碍内心境不一致精神病性特征关联最强(RR=1.46)。
  • 多基因风险评分或有助于超越传统诊断分类进行患者分层。

核心结论

  • 精神分裂症多基因风险评分与双相障碍的心境不一致精神病性症状存在暴露-反应梯度关联。

研究设计与样本

  • 英国病例对照研究,纳入4436例双相障碍患者,比较4976例精神分裂症和9012名对照的基因型数据。
  • 使用多项逻辑回归估计多基因风险评分在不同诊断类别间的差异关联,数据收集于2000年1月1日至2013年12月31日。

主要发现

  • 多基因风险评分与精神分裂症关联最强(RR=1.94;95%CI,1.86-2.01),其次为分裂情感性双相障碍(RR=1.37;95%CI,1.22-1.54)、双相I型(RR=1.30;95%CI,1.24-1.36)、双相II型(RR=1.04;95%CI,0.97-1.11)。
  • 双相障碍内心境不一致精神病性特征关联最强(RR=1.46;95%CI,1.36-1.57),其次为心境一致精神病性症状(RR=1.24;95%CI,1.17-1.33)和无精神病性病史(RR=1.09;95%CI,1.04-1.15)。

关键数值与推荐

  • 多基因风险评分基于精神分裂症全基因组关联研究中使用P<.05等位基因计算,并校正前10个群体主成分和基因分型平台。
  • 双相障碍亚型依据研究诊断标准划分,精神病性特征采用Schedules for Clinical Assessment in Neuropsychiatry访谈和Bipolar Affective Disorder Dimension Scale评估。

临床怎么用

  • 精神分裂症多基因风险评分可用于识别双相障碍中心境不一致精神病性症状更突出的患者亚群。
  • 该梯度关联提示双相障碍与精神分裂症在遗传易感上存在连续谱系,支持超越传统诊断分类进行分层。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Bipolar disorder (BD) overlaps schizophrenia in its clinical presentation and genetic liability. Alternative approaches to patient stratification beyond current diagnostic categories are needed to understand the underlying disease processes and mechanisms. OBJECTIVE: To investigate the association between common-variant liability for schizophrenia, indexed by polygenic risk scores (PRSs), and psychotic presentations of BD. DESIGN, SETTING, AND PARTICIPANTS: This case-control study in the United Kingdom used multinomial logistic regression to estimate differential PRS associations across categories of cases and controls. Participants included in the final analyses were 4436 cases of BD from the Bipolar Disorder Research Network. These cases were compared with the genotypic data for 4976 cases of schizophrenia and 9012 controls from the Type 1 Diabetes Genetics Consortium study and the Generation Scotland study. Data were collected between January 1, 2000, and December 31, 2013. Data analysis was conducted from March 1, 2016, to February 28, 2017. EXPOSURES: Standardized PRSs, calculated using alleles with an association threshold of P < .05 in the second Psychiatric Genomics Consortium genome-wide association study of schizophrenia, were adjusted for the first 10 population principal components and genotyping platforms. MAIN OUTCOMES AND MEASURES: Multinomial logit models estimated PRS associations with BD stratified by Research Diagnostic Criteria subtypes of BD, by lifetime occurrence of psychosis, and by lifetime mood-incongruent psychotic features. Ordinal logistic regression examined PRS associations across levels of mood incongruence. Ratings were derived from the Schedules for Clinical Assessment in Neuropsychiatry interview and the Bipolar Affective Disorder Dimension Scale. RESULTS: Of the 4436 cases of BD, 2966 (67%) were female patients, and the mean (SD) age at interview was 46 [12] years. Across clinical phenotypes, there was an exposure-response gradient, with the strongest PRS association for schizophrenia (risk ratio [RR] = 1.94; 95% CI, 1.86-2.01), followed by schizoaffective BD (RR = 1.37; 95% CI, 1.22-1.54), bipolar I disorder subtype (RR = 1.30; 95% CI, 1.24-1.36), and bipolar II disorder subtype (RR = 1.04; 95% CI, 0.97-1.11). Within BD cases, there was an effect gradient, indexed by the nature of psychosis. Prominent mood-incongruent psychotic features had the strongest association (RR = 1.46; 95% CI, 1.36-1.57), followed by mood-congruent psychosis (RR = 1.24; 95% CI, 1.17-1.33) and BD with no history of psychosis (RR = 1.09; 95% CI, 1.04-1.15). CONCLUSIONS AND RELEVANCE: For the first time to date, a study shows a polygenic-risk gradient across schizophrenia and BD, indexed by the occurrence and level of mood-incongruent psychotic symptoms.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Allardyce J, Leonenko G, Hamshere M, et al. Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder. JAMA Psychiatry. 2018. PMID: 29167880. doi:10.1001/jamapsychiatry.2017.3485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。